Aiqin Gao

1.7k total citations
38 papers, 1.3k citations indexed

About

Aiqin Gao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Aiqin Gao has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 19 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Aiqin Gao's work include Cancer Immunotherapy and Biomarkers (17 papers), Immune Cell Function and Interaction (14 papers) and Immune cells in cancer (10 papers). Aiqin Gao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Immune Cell Function and Interaction (14 papers) and Immune cells in cancer (10 papers). Aiqin Gao collaborates with scholars based in China, United States and Spain. Aiqin Gao's co-authors include Yuping Sun, Guangyong Peng, Fusheng Si, Daniel F. Hoft, Wenli Lin, Jingnan Wang, Eddy C. Hsueh, David A. Ford, Linlin Wang and Yangjing Zhao and has published in prestigious journals such as Journal of Clinical Oncology, Cell Metabolism and Journal of Cell Science.

In The Last Decade

Aiqin Gao

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiqin Gao China 16 669 577 391 289 208 38 1.3k
Lucy Ireland United Kingdom 10 408 0.6× 516 0.9× 353 0.9× 206 0.7× 138 0.7× 15 993
Yu Rebecca Miao United States 17 445 0.7× 506 0.9× 601 1.5× 330 1.1× 232 1.1× 28 1.3k
Natasha M. Savage United States 18 585 0.9× 557 1.0× 488 1.2× 161 0.6× 147 0.7× 79 1.4k
Jérémy Bastid France 15 480 0.7× 888 1.5× 697 1.8× 295 1.0× 143 0.7× 22 1.6k
Maxime Meylan France 9 700 1.0× 850 1.5× 389 1.0× 231 0.8× 308 1.5× 24 1.4k
Alisha Holtzhausen United States 14 727 1.1× 628 1.1× 625 1.6× 201 0.7× 111 0.5× 22 1.3k
Guohui Qin China 19 482 0.7× 466 0.8× 542 1.4× 322 1.1× 140 0.7× 35 1.1k
Shenghua Zhan China 16 312 0.5× 377 0.7× 435 1.1× 267 0.9× 110 0.5× 34 954
Rindert Missiaen United States 8 336 0.5× 449 0.8× 432 1.1× 265 0.9× 155 0.7× 9 962
Xiaobin Lin China 8 477 0.7× 508 0.9× 502 1.3× 328 1.1× 163 0.8× 16 1.1k

Countries citing papers authored by Aiqin Gao

Since Specialization
Citations

This map shows the geographic impact of Aiqin Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiqin Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiqin Gao more than expected).

Fields of papers citing papers by Aiqin Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiqin Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiqin Gao. The network helps show where Aiqin Gao may publish in the future.

Co-authorship network of co-authors of Aiqin Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Aiqin Gao. A scholar is included among the top collaborators of Aiqin Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiqin Gao. Aiqin Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Dawei, Aiqin Gao, Bing Zou, et al.. (2024). Overall survival of adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line treatment for extensive-stage small cell lung cancer.. Journal of Clinical Oncology. 42(16_suppl). 8014–8014. 3 indexed citations
3.
4.
Chen, Dawei, Bing Zou, Butuo Li, et al.. (2024). Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial. EClinicalMedicine. 75. 102795–102795. 13 indexed citations
5.
Gong, Wenjing, Jian Wang, Xiaojuan Wei, et al.. (2024). Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study. Cancer Medicine. 13(2). e6960–e6960. 1 indexed citations
6.
Gao, Aiqin, et al.. (2023). ILT4 reprograms glucose metabolism to promote tumor progression in triple-negative breast cancer. Journal of Cell Science. 136(18). 4 indexed citations
7.
Shi, Wenjing, Fang Zhang, Zijiang Yang, et al.. (2022). Tumor‐derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer. Cancer Science. 113(6). 1939–1954. 12 indexed citations
8.
Wang, Shuyun, Yuxiao Song, Fang Zhang, et al.. (2022). Neurturin promotes tumor cell motility and angiogenesis in colorectal cancer. Experimental Cell Research. 413(1). 113049–113049. 9 indexed citations
9.
Tian, Yuan, et al.. (2022). The Significance of Tumor Microenvironment Score for Breast Cancer Patients. BioMed Research International. 2022(1). 5673810–5673810. 4 indexed citations
10.
Liu, Xia, Celine L. Hartman, Lingyun Li, et al.. (2021). Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Science Translational Medicine. 13(587). 200 indexed citations
11.
Tian, Yuan, Ran Li, Yan Liu, et al.. (2021). The Risk of Immune-Related Thyroid Dysfunction Induced by PD-1/PD-L1 Inhibitors in Cancer Patients: An Updated Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 667650–667650. 9 indexed citations
12.
Li, Juan, Aiqin Gao, Fang Zhang, et al.. (2020). ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer. Cancer Letters. 501. 263–276. 41 indexed citations
13.
Tian, Yuan, Aiqin Gao, Qing Wen, et al.. (2020). Immune-Related Neurological Toxicities of PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 11. 595655–595655. 9 indexed citations
14.
Li, Hao, et al.. (2020). Changes of miR‑155 expression in serum of uremic patients before and after treatment and risk factors analysis. Experimental and Therapeutic Medicine. 20(4). 3352–3360. 7 indexed citations
15.
Wang, Jingnan, et al.. (2019). The prognostic landscape of tumor-infiltrating immune cells in cervical cancer. Biomedicine & Pharmacotherapy. 120. 109444–109444. 78 indexed citations
16.
Li, Lingyun, Xia Liu, James L. Edwards, et al.. (2018). TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy. Cell Metabolism. 29(1). 103–123.e5. 189 indexed citations
17.
Li, Juan, et al.. (2018). Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance. Journal of Cancer Research and Therapeutics. 14(7). 1655–1655. 14 indexed citations
18.
Wang, Shuyun, Aiqin Gao, Jie Liu, & Yuping Sun. (2018). First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice?. Cancer Chemotherapy and Pharmacology. 81(3). 443–453. 11 indexed citations
19.
20.
Li, Juan, Han Chen, Xiaoqing Li, et al.. (2017). Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma. Molecular Medicine Reports. 16(2). 1643–1652. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucy Ireland Breakdown of academic impact, for papers by Yu Rebecca Miao Breakdown of academic impact, for papers by Natasha M. Savage Breakdown of academic impact, for papers by Jérémy Bastid Breakdown of academic impact, for papers by Maxime Meylan Breakdown of academic impact, for papers by Alisha Holtzhausen Breakdown of academic impact, for papers by Guohui Qin Breakdown of academic impact, for papers by Shenghua Zhan Breakdown of academic impact, for papers by Rindert Missiaen Breakdown of academic impact, for papers by Xiaobin Lin
Rankless by CCL
2026